Opportunity Information: Apply for USAID SENEGAL RFA 685 11 A 11
Apply for USAID SENEGAL RFA 685 11 A 11
- The Senegal USAID Dakar in the health sector is offering a public funding opportunity titled "HIV/AIDS and TB (HIV/TB) Program Component" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Mar 15, 2011 and posted on Feb 7, 2011.
- Applicants must submit their applications by Apr 19, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $22,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The HIV/AIDS and TB (HIV/TB) Program Component is a USAID/Senegal funding opportunity designed to strengthen Senegal's national response to HIV and tuberculosis by pairing financial resources with hands-on technical assistance and institutional support. The core intent is to help the Government of Senegal and its implementing partners sustain Senegal's comparatively low national HIV prevalence while also addressing concentrated epidemics in specific locations and among groups at higher risk. In practical terms, the activity emphasizes focused support that improves how national and local systems plan, manage, and deliver HIV and TB services, rather than only funding isolated, short-term interventions.
On the HIV side, the opportunity prioritizes prevention efforts aimed at reducing transmission where prevalence is higher and among most-at-risk populations (MARPs). It also seeks to improve both the quality and the availability of treatment, care, and support services for people living with HIV (PLWHIV). That framing suggests a strong interest in initiatives that strengthen service delivery and systems of care, such as improving clinical quality, expanding access points, building workforce capacity, improving supply and logistics, and reinforcing linkages between prevention, testing, and treatment so that people can move smoothly through the continuum of care.
On the TB side, the opportunity highlights improved detection and treatment of tuberculosis, which commonly overlaps with HIV programming due to co-infection risks and shared health system needs. The stated goals point to efforts that enhance case finding, diagnostic capacity, referral networks, treatment initiation, adherence support, and program monitoring. Because the opportunity combines HIV and TB in one component, it implicitly supports more integrated approaches where feasible, including coordination between HIV and TB services, shared data and surveillance improvements, and health facility or community systems that can manage both conditions effectively.
Administratively, this is a discretionary award funded under CFDA 98.001 (USAID Foreign Assistance for Programs Overseas) and will be implemented through a cooperative agreement, meaning USAID anticipates substantial involvement during implementation (for example, in work planning, technical direction, and oversight). The anticipated number of awards is one, indicating USAID likely intended to select a single prime implementer to lead and coordinate activities. The award ceiling listed is $22,000,000, setting the maximum amount expected for the agreement. Cost sharing or matching is required, so applicants would need to contribute resources (cash and/or in-kind, as defined in the full announcement) as part of the application and implementation plan. Eligibility is listed as unrestricted, meaning any type of entity could apply unless additional eligibility constraints were specified in the full solicitation.
The opportunity was posted on February 7, 2011, with an original and current closing date of April 19, 2011, and it was archived on May 19, 2011, indicating it is no longer open. The issuing office is USAID Dakar, and the listed contact for access issues with the full announcement is Salamata Ly, Acquisition and Assistance Specialist, reachable by phone at (221) 33 869 61 00.
Frequently Asked Questions (FAQs): USAID/Senegal HIV/AIDS and TB (HIV/TB) Program Component
What is this funding opportunity?
This is a USAID/Senegal funding opportunity for an HIV/AIDS and tuberculosis (HIV/TB) Program Component designed to strengthen Senegal's national response to HIV and TB. It combines financial support with hands-on technical assistance and institutional support, with an emphasis on improving how systems plan, manage, and deliver services.
What is the main purpose of the program?
The core intent is to help the Government of Senegal and implementing partners sustain Senegal's comparatively low national HIV prevalence while also addressing concentrated epidemics in specific locations and among groups at higher risk. The program focuses on strengthening national and local systems rather than funding only isolated, short-term interventions.
Which health areas does the program cover?
The program covers both HIV/AIDS and tuberculosis (TB), including areas where HIV and TB programming overlap due to co-infection risks and shared health system needs.
What HIV priorities are emphasized?
On the HIV side, the opportunity prioritizes prevention efforts aimed at reducing transmission where prevalence is higher and among most-at-risk populations (MARPs). It also aims to improve the quality and availability of treatment, care, and support services for people living with HIV (PLWHIV).
What kinds of HIV activities appear to fit this opportunity?
Based on the stated emphasis, relevant HIV activities would likely include strengthening service delivery and systems of care, such as improving clinical quality, expanding access points, building workforce capacity, improving supply and logistics, and reinforcing linkages across prevention, testing, and treatment to support a smooth continuum of care.
What TB priorities are emphasized?
On the TB side, the opportunity highlights improved detection and treatment of tuberculosis. It points toward strengthening case finding, diagnostic capacity, referral networks, treatment initiation, adherence support, and program monitoring.
Does the opportunity support integrated HIV and TB approaches?
Yes. Because HIV and TB are combined in one component, the description implicitly supports integrated approaches where feasible, including coordination between HIV and TB services, shared data and surveillance improvements, and facility or community systems that can manage both conditions effectively.
Is this a grant or a contract?
The opportunity is described as a discretionary award implemented through a cooperative agreement.
What does "cooperative agreement" mean in this context?
A cooperative agreement means USAID anticipates substantial involvement during implementation. Examples noted include involvement in work planning, technical direction, and oversight.
What is the CFDA number for this opportunity?
The opportunity is funded under CFDA 98.001, described as USAID Foreign Assistance for Programs Overseas.
How many awards were anticipated?
The anticipated number of awards is one, suggesting USAID intended to select a single prime implementer to lead and coordinate activities.
What is the maximum funding amount available?
The award ceiling listed is $22,000,000, which sets the maximum amount expected for the cooperative agreement.
Is cost sharing or matching required?
Yes. Cost sharing or matching is required, meaning applicants would need to contribute resources (cash and/or in-kind, as defined in the full announcement) as part of the application and implementation plan.
Who was eligible to apply?
Eligibility is listed as unrestricted, meaning any type of entity could apply unless additional eligibility constraints were specified in the full solicitation.
When was the opportunity posted?
The opportunity was posted on February 7, 2011.
What was the closing date for applications?
The original and current closing date listed is April 19, 2011.
Is this opportunity still open?
No. It was archived on May 19, 2011, which indicates it is no longer open for applications.
Which USAID office issued this opportunity?
The issuing office is USAID Dakar.
Who is the point of contact for access issues with the full announcement?
The contact listed for access issues is Salamata Ly, Acquisition and Assistance Specialist.
How can the listed contact be reached?
The phone number provided is (221) 33 869 61 00.
What overall approach does this opportunity emphasize?
The description emphasizes focused support that improves national and local systems responsible for planning, management, and delivery of HIV and TB services, rather than funding stand-alone or short-term activities.
Which populations are highlighted on the HIV prevention side?
The opportunity highlights prevention among most-at-risk populations (MARPs) and in locations where HIV prevalence is higher, alongside maintaining Senegal's comparatively low national HIV prevalence.
What service delivery improvements are specifically suggested for HIV?
The description points to improvements such as clinical quality strengthening, expanded access points, workforce capacity building, better supply and logistics, and stronger linkages between prevention, testing, and treatment to improve movement through the continuum of care.
What system-strengthening improvements are specifically suggested for TB?
The description points toward stronger case finding and detection, improved diagnostics, better referral networks, support for treatment initiation, adherence support, and improved program monitoring.
Why are HIV and TB combined in a single program component?
The description notes overlap between HIV and TB due to co-infection risks and shared health system needs, which supports coordination and integration where feasible.
Browse more opportunities from the same agency: Senegal USAID Dakar
Browse more opportunities from the same category: Health
Next opportunity: Health System Strenghtening (HSS) Program Component
Previous opportunity: Transit Track Worker Safety Protection Demonstration Project
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for USAID SENEGAL RFA 685 11 A 11
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (USAID SENEGAL RFA 685 11 A 11) also looked into and applied for these:
| Funding Opportunity |
|---|
| Health System Strenghtening (HSS) Program Component Apply for USAID SENEGAL RFA 685 11 A 12 Funding Number: USAID SENEGAL RFA 685 11 A 12 Agency: Senegal USAID Dakar Category: Health Funding Amount: $20,000,000 |
| Health Services Improvement (HSI) Program Component Apply for USAID SENEGAL RFA 685 11 A 13 Funding Number: USAID SENEGAL RFA 685 11 A 13 Agency: Senegal USAID Dakar Category: Health Funding Amount: $32,000,000 |
| Strengthening the Human Resource Capacity in the Republic of Zambia to Provide Quality Care for HIV/AIDS through the Development of a Cadre of Local Experts in HIV/AIDS under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1118 Funding Number: CDC RFA GH11 1118 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| The National Healthy Tomorrows Technical Assistance Resource Center Apply for HRSA 11 125 Funding Number: HRSA 11 125 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Community Health (CH) Program Component Apply for USAID SENEGAL RFA 685 11 A 14 Funding Number: USAID SENEGAL RFA 685 11 A 14 Agency: Senegal USAID Dakar Category: Health Funding Amount: $40,000,000 |
| Strengthening Local Ownership for the Sustainable Provision of HIV/AIDS Services in the Regional Health Bureaus of Oromiya and Harari Regional States and Dire Dawa City Administration of the Federal Democratic Republic of Ethiopia under PEPFAR Apply for CDC RFA GH11 1106 Funding Number: CDC RFA GH11 1106 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Building the Capacity of Provincial Medical Offices (PHOs) in the Republic of Zambia to Provide Comprehensive and Sustainable HIV/AIDS Prevention, Care, Support, and Treatment Services in Eastern, Lusaka, and Western Provinces of the Republic of Zamb Apply for CDC RFA GH11 1122 Funding Number: CDC RFA GH11 1122 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Engaging Local Indigenous Partners in the Implementation and Expansion of High Quality HIV Care, Prevention and Treatment Activities in Faith Based, Affiliated Sites in the Republic of Kenya under the President s Emergency Plan for AIDS Relief (PEPFA Apply for CDC RFA GH11 1103 Funding Number: CDC RFA GH11 1103 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Provision of Comprehensive HIV/AIDS Care, Treatment and Prevention Services in Faith Based Health Facilities and Procurement and Logistics Management of Health Related Commodities for HHS/CDC Funded HIV/AIDS Programs in the Republic of Uganda under P Apply for CDC RFA GH11 1113 Funding Number: CDC RFA GH11 1113 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Child and Adolescent Injury and Violence Prevention Resource Centers Cooperative Agreement Apply for HRSA 11 103 Funding Number: HRSA 11 103 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Implementation of Programs for the Prevention, Care and Treatment of HIV/AIDS in the Republic of Cote d Ivoire under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1116 Funding Number: CDC RFA GH11 1116 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening Integrated Delivery of HIV/AIDS Services (SIDHAS) Apply for USAID NIGERIA HIV 11 004 RFA Funding Number: USAID NIGERIA HIV 11 004 RFA Agency: Nigeria USAID Abuja Category: Health Funding Amount: $225,000,000 |
| Engaging Local Indigenous Organizations in the Implementation and Provision of Comprehensive HIV Care, Treatment, and Prevention Services in Six States of the Federal Republic of Nigeria under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1124 Funding Number: CDC RFA GH11 1124 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Supporting Indigenous Organizations to Implement and Expand Comprehensive HIV/AIDS Prevention, Care and Treatment in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1130 Funding Number: CDC RFA GH11 1130 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Improving Care And Treatment For TB/HIV Co Infected Children Through The Establishment Of Comprehensive Pediatric TB/HIV Activities In The United Republic Of Tanzania Under The President s Emergency Plan For AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1107 Funding Number: CDC RFA GH11 1107 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Improving Implementation of Programs for Care Treatment of HIV/AIDS in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1129 Funding Number: CDC RFA GH11 1129 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening Local Capacity to Provide Sustainable HIV Related Care and Treatment Services in South Africa under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1109 Funding Number: CDC RFA GH11 1109 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Operations Research (Implementation Science) for Strengthening Program Implementation through the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for RFA GH 11 005 Funding Number: RFA GH 11 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| MCH Autism Intervention Research Apply for HRSA 11 084 Funding Number: HRSA 11 084 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Autism Intervention Research Network on Physical Health Apply for HRSA 11 078 Funding Number: HRSA 11 078 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "USAID SENEGAL RFA 685 11 A 11", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.